131 results
Page 5 of 7
8-K
EX-4.3
p7p c2de2nzio1
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-4.1
qgip287mm1i66b
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-10.1
252f 0cqboytnp
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
37wo6bsbb1fitf74
13 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
EX-4.2
ifgrgln8v
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
frb6bxplejh8xe
23 Dec 10
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
as5bfzpscd6qbvf4
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
nhacovfbugdlntr co
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
POS AM
4bqjn yjn29qcomzs4
27 Jul 10
Prospectus update (post-effective amendment)
12:00am
424B3
0fpihk42rfxju5
5 Apr 10
Prospectus supplement
12:00am
8-K
EX-10.1
ef9t xwq18
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
8-K
EX-3.1
c5il4s5kiuzws7fztlz
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
8-K
EX-10.2
c053ifno 1o
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
CORRESP
wb7rrkz7x3z
22 Sep 09
Correspondence with SEC
12:00am